Todd Shearer

Todd Shearer is an experienced biopharmaceutical executive currently serving as Vice President at Cullinan Therapeutics since June 2023. Previously, Todd held the position of Vice President and Senior Director of Clinical Pharmacology at SpringWorks Therapeutics, contributing to the development of treatments for rare diseases and cancer from January 2019 to June 2023. Todd's extensive background includes serving as Executive Director of Nonclinical and Clinical Pharmacology at Nuventra Pharma Sciences and Director of Drug Metabolism and Pharmacokinetics at GlaxoSmithKline. With a strong foundation in drug development and pharmacology, Todd's career commenced in the US Army as a Captain and Biochemist. Todd holds a PhD in Molecular and Cellular Biology, an MS in Environmental Studies, and a BS in Biology.